Diabetes and Endocrinology

Held from October 25–27, 2027, in Orlando, Florida, USA, and Online, the "5th Edition of International Conference on Diabetes and Endocrinology" (Diabetes 2027) will bring the diabetes and endocrine community together for three days of scientific exchange. Guided by the theme “Advancing Diabetes and Endocrine Care through Research and Innovation,” the conference offers a global platform for presenting research and clinical advances in the prevention, diagnosis, and management of diabetes and hormonal disorders.

Diabetes 2027 is intended for endocrinologists, diabetologists, internal medicine and primary care physicians, pediatric endocrinologists, diabetes educators, nurses, dietitians, pharmacists, clinical researchers, academicians, students, and pharmaceutical and medical technology professionals. The conference supports the exchange of clinical experience and research findings and encourages collaborations that improve care for people living with endocrine conditions.

Sessions will explore type 1 and type 2 diabetes, prediabetes and prevention, gestational diabetes, diabetes technology including continuous glucose monitoring and insulin pumps, novel glucose-lowering therapies, diabetic complications, obesity and metabolic syndrome, thyroid and parathyroid disorders, adrenal and pituitary diseases, reproductive endocrinology, bone and mineral metabolism, endocrine oncology, and precision medicine in endocrinology.

The program features keynote lectures, plenary sessions, oral and poster presentations, workshops, panel discussions, young researcher forums, exhibitions, and networking sessions. We look forward to welcoming you to Orlando, Florida, USA, or online for a productive meeting that advances diabetes and endocrine care worldwide.